BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 27835864)

  • 21. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
    Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
    Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma.
    Kunou S; Shimada K; Takai M; Sakamoto A; Aoki T; Hikita T; Kagaya Y; Iwamoto E; Sanada M; Shimada S; Hayakawa F; Oneyama C; Kiyoi H
    Oncogene; 2021 Jun; 40(23):3989-4003. PubMed ID: 33994542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.
    Agnusdei V; Minuzzo S; Frasson C; Grassi A; Axelrod F; Satyal S; Gurney A; Hoey T; Seganfreddo E; Basso G; Valtorta S; Moresco RM; Amadori A; Indraccolo S
    Leukemia; 2014 Feb; 28(2):278-88. PubMed ID: 23774673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.
    Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM
    Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.
    Poglio S; Lewandowski D; Calvo J; Caye A; Gros A; Laharanne E; Leblanc T; Landman-Parker J; Baruchel A; Soulier J; Ballerini P; Clappier E; Pflumio F
    Oncotarget; 2016 Jul; 7(27):41599-41611. PubMed ID: 27191650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
    Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
    Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.
    Guillén Díaz-Maroto N; Sanz-Pamplona R; Berdiel-Acer M; Cimas FJ; García E; Gonçalves-Ribeiro S; Albert N; Garcia-Vicién G; Capella G; Moreno V; Salazar R; Villanueva A; Molleví DG
    Clin Cancer Res; 2019 Jul; 25(14):4466-4479. PubMed ID: 30979739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.
    Marchesini M; Gherli A; Montanaro A; Patrizi L; Sorrentino C; Pagliaro L; Rompietti C; Kitara S; Heit S; Olesen CE; Møller JV; Savi M; Bocchi L; Vilella R; Rizzi F; Baglione M; Rastelli G; Loiacono C; La Starza R; Mecucci C; Stegmaier K; Aversa F; Stilli D; Lund Winther AM; Sportoletti P; Bublitz M; Dalby-Brown W; Roti G
    Cell Chem Biol; 2020 Jun; 27(6):678-697.e13. PubMed ID: 32386594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance.
    Yan ZX; Zheng Z; Xue W; Zhao MZ; Fei XC; Wu LL; Huang LM; Leboeuf C; Janin A; Wang L; Zhao WL
    Biomed Res Int; 2015; 2015():197241. PubMed ID: 26436088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-leukemia effect of oridonin on T-cell acute lymphoblastic leukemia].
    Guo Y; Shan QQ; Gong YP; Lin J; Yang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):903-7. PubMed ID: 25571712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AKR1C enzymes sustain therapy resistance in paediatric T-ALL.
    Bortolozzi R; Bresolin S; Rampazzo E; Paganin M; Maule F; Mariotto E; Boso D; Minuzzo S; Agnusdei V; Viola G; Te Kronnie G; Cazzaniga G; Basso G; Persano L
    Br J Cancer; 2018 Apr; 118(7):985-994. PubMed ID: 29515258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance.
    Yamauchi T; Ogawa M; Ueda T
    Mol Pharmacol; 2008 Jul; 74(1):82-91. PubMed ID: 18430789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia.
    Correia NC; Fragoso R; Carvalho T; Enguita FJ; Barata JT
    Sci Rep; 2016 Aug; 6():31894. PubMed ID: 27550837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia.
    Kumagai M; Manabe A; Coustan-Smith E; Blakley RL; Beck WT; Santana VM; Behm FG; Raimondi SC; Campana D
    Leukemia; 1994 Jul; 8(7):1116-23. PubMed ID: 7913512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth.
    Guan X; LaPak KM; Hennessey RC; Yu CY; Shakya R; Zhang J; Burd CE
    Mol Cancer Res; 2017 Mar; 15(3):237-249. PubMed ID: 28039358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone.
    Xiang J; Wang G; Xia T; Chen Z
    Biomed Pharmacother; 2019 Jan; 109():2210-2217. PubMed ID: 30551478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
    Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
    Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
    Zhang X; Huang H; Xu Z; Zhan R
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples.
    Lu BY; Thanawala SU; Zochowski KC; Burke MJ; Carroll WL; Bhatla T
    Leuk Lymphoma; 2016 Aug; 57(8):1938-41. PubMed ID: 26726842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.